2001
DOI: 10.1046/j.1365-4362.2001.01060.x
|View full text |Cite
|
Sign up to set email alerts
|

Dermatomyositis and mucinosis

Abstract: Mucin deposition in patients with dermatomyositis may have an unusual clinical presentation, and it should be considered in the differential diagnosis of atypical cutaneous lesions in these patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
20
0

Year Published

2004
2004
2024
2024

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(22 citation statements)
references
References 21 publications
2
20
0
Order By: Relevance
“…12 In addition, patients with dermatomyositis may develop atypical clinical lesions secondary to cutaneous mucin deposition. 13 To date, markers of autoimmune disease including antinuclear antibody, rheumatoid factor, and complement levels in several of the reported cases of SHJCM have not revealed evidence of autoimmunity. 3,4,[6][7][8] Taken together, however, we believe patients suggested to have SHJCM should at minimum be evaluated with creatine kinase and aldolase testing for the presence of elevated muscle enzymes.…”
Section: Discussionmentioning
confidence: 98%
“…12 In addition, patients with dermatomyositis may develop atypical clinical lesions secondary to cutaneous mucin deposition. 13 To date, markers of autoimmune disease including antinuclear antibody, rheumatoid factor, and complement levels in several of the reported cases of SHJCM have not revealed evidence of autoimmunity. 3,4,[6][7][8] Taken together, however, we believe patients suggested to have SHJCM should at minimum be evaluated with creatine kinase and aldolase testing for the presence of elevated muscle enzymes.…”
Section: Discussionmentioning
confidence: 98%
“…Pandya et al linked the increased level of serum autoantibody titres with an increase in mucin lesions in patients with SLE [11, 15]. Interleukin-1 and interleukin-6 have also been shown to be elevated in patients with increased dermal mucin production in SLE and DM; however this is nonspecific as interleukins may be raised without evidence of mucinosis [2]. …”
Section: Discussionmentioning
confidence: 99%
“…Clinically evident forms of mucinosis have been described in hypothyroidism, thyrotoxicosis, scleromyxedema associated with monoclonal gammopathies, scleredema related to diabetes, and lichen myxedematosus. Cases of secondary cutaneous mucinosis have been described in systemic lupus erythematosus, systemic sclerosis, and dermatomyositis, albeit infrequently [28]. We present a case of dermatomyositis with evidence of diffuse cutaneous mucinosis in a patient recently treated for nonsmall cell lung cancer (NSCLC) without evidence of recurrence.…”
Section: Introductionmentioning
confidence: 99%
“…(7,10,11) Skin biopsy can show chronic perivascular and peri-adnexal inflammation, and mucin deposits are common findings. (12) In addition, CD4+ cells can be found in the dermis. (11) Muscle involvement is suspected when proximal and progressive symmetric weakness, manifesting as inability to climb stairs or raise the arms, is reported.…”
Section: Discussionmentioning
confidence: 99%